Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Vaage-Nilsen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cardiovascular Drugs and Therapy|October 24, 1998
Effect of verapamil on heart rate variability after an acute myocardial infarction. Danish Verapamil Infarction Trial IIM Vaage-Nilsen, V Rasmussen
Clinical Cardiology|February 1, 1993
Ventricular arrhythmias in patients recovering from myocardial infarction: do residual myocardial ischemia and anti-ischemic medical intervention influence the one-month prevalence? The Danish Study Group on Verapamil in Myocardial InfarctionC M Jespersen, M Vaage-Nilsen
European Heart Journal|October 1, 1992
The significance of myocardial ischaemia and verapamil treatment on the prevalence of supraventricular tachyarrhythmias in patients recovering from acute myocardial infarction. Danish Study Group on Verapamil in Myocardial InfarctionC M Jespersen, M Vaage-Nilsen, J F Hansen
American Heart Journal|May 29, 1999
ST-segment deviation during 24-hour ambulatory electrocardiographic monitoring and exercise stress test in healthy male subjects 51 to 75 years of age: the Copenhagen City Heart StudyM Vaage-Nilsen, V Rasmussen, C Sørum, et al.
European Heart Journal|May 1, 1992
Prevalence of transient myocardial ischaemia during the first year after a myocardial infarction. Effect of treatment with verapamil. The Danish Study Group on Verapamil in Myocardial InfarctionM Vaage-Nilsen, V Rasmussen, N H Holländer, et al.
Scandinavian Cardiovascular Journal : SCJ|August 23, 2001
Recovery of autonomic nervous activity after myocardial infarction demonstrated by short-term measurements of SDNNM Vaage-Nilsen, V Rasmussen, G Jensen, et al.
International Journal of Cardiology|June 1, 1993
The prevalence of myocardial ischemia six months after thrombolytic treatment of acute coronary episodes. A subset of a placebo controlled, randomised trial, the ASSET StudyM Vaage-Nilsen, P Aurup, A Høegholm, et al.
International Journal of Cardiology|March 3, 1995
Effect of verapamil on the prognosis of patients with early postinfarction electrical or mechanical complications. The Danish Verapamil Infarction Trial II (DAVIT II)M Vaage-Nilsen, J F Hansen, K Mellemgaard, et al.
Cardiology|January 1, 1995
Short- and long-term prognostic implications of in-hospital postinfarction arrhythmias. DAVIT II Study GroupM Vaage-Nilsen, J F Hansen, K Mellemgaard, et al.
Journal of Cardiovascular Pharmacology|January 1, 1991
Effect of verapamil on ischemia and ventricular arrhythmias after an acute myocardial infarction: prognostic implications. The Danish Verapamil Infarction Trial II Study GroupM Vaage-Nilsen, V Rasmussen, J F Hansen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cardiovascular Drugs and Therapy|October 24, 1998
Effect of verapamil on heart rate variability after an acute myocardial infarction. Danish Verapamil Infarction Trial IIM Vaage-Nilsen, V Rasmussen
Clinical Cardiology|February 1, 1993
Ventricular arrhythmias in patients recovering from myocardial infarction: do residual myocardial ischemia and anti-ischemic medical intervention influence the one-month prevalence? The Danish Study Group on Verapamil in Myocardial InfarctionC M Jespersen, M Vaage-Nilsen
European Heart Journal|October 1, 1992
The significance of myocardial ischaemia and verapamil treatment on the prevalence of supraventricular tachyarrhythmias in patients recovering from acute myocardial infarction. Danish Study Group on Verapamil in Myocardial InfarctionC M Jespersen, M Vaage-Nilsen, J F Hansen
American Heart Journal|May 29, 1999
ST-segment deviation during 24-hour ambulatory electrocardiographic monitoring and exercise stress test in healthy male subjects 51 to 75 years of age: the Copenhagen City Heart StudyM Vaage-Nilsen, V Rasmussen, C Sørum, et al.
European Heart Journal|May 1, 1992
Prevalence of transient myocardial ischaemia during the first year after a myocardial infarction. Effect of treatment with verapamil. The Danish Study Group on Verapamil in Myocardial InfarctionM Vaage-Nilsen, V Rasmussen, N H Holländer, et al.
Scandinavian Cardiovascular Journal : SCJ|August 23, 2001
Recovery of autonomic nervous activity after myocardial infarction demonstrated by short-term measurements of SDNNM Vaage-Nilsen, V Rasmussen, G Jensen, et al.
International Journal of Cardiology|June 1, 1993
The prevalence of myocardial ischemia six months after thrombolytic treatment of acute coronary episodes. A subset of a placebo controlled, randomised trial, the ASSET StudyM Vaage-Nilsen, P Aurup, A Høegholm, et al.
International Journal of Cardiology|March 3, 1995
Effect of verapamil on the prognosis of patients with early postinfarction electrical or mechanical complications. The Danish Verapamil Infarction Trial II (DAVIT II)M Vaage-Nilsen, J F Hansen, K Mellemgaard, et al.
Cardiology|January 1, 1995
Short- and long-term prognostic implications of in-hospital postinfarction arrhythmias. DAVIT II Study GroupM Vaage-Nilsen, J F Hansen, K Mellemgaard, et al.
Journal of Cardiovascular Pharmacology|January 1, 1991
Effect of verapamil on ischemia and ventricular arrhythmias after an acute myocardial infarction: prognostic implications. The Danish Verapamil Infarction Trial II Study GroupM Vaage-Nilsen, V Rasmussen, J F Hansen, et al.
Pageof 2